Inspire Medical Systems (INSP) Long-Term Deferred Tax (2017 - 2026)

Inspire Medical Systems (INSP) has 5 years of Long-Term Deferred Tax data on file, last reported at $87.7 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $87.7 million; the trailing twelve-month figure through Mar 2026 stood at $87.7 million (changed N/A YoY), and the FY2025 full-year result was $88.7 million, up 681953.85% from the prior year.
• Long-Term Deferred Tax fell to $87.7 million in Q1 2026, from $88.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $88.7 million in Q4 2025 to a low of $13000.0 in Q4 2024.
• A 3-year average of $58.8 million and a median of $87.7 million in 2026 frame the typical range for Long-Term Deferred Tax.
• Peak annual rise in Long-Term Deferred Tax reached 681953.85% in 2025, while the deepest fall reached 681953.85% in 2025.
• Tracing INSP's Long-Term Deferred Tax over 3 years: stood at $13000.0 in 2024, then soared by 681953.85% to $88.7 million in 2025, then slipped by 1.13% to $87.7 million in 2026.
• Business Quant data shows INSP's Long-Term Deferred Tax at $87.7 million in Q1 2026, $88.7 million in Q4 2025, and $13000.0 in Q4 2024.